Please visit jdrf.org/2012annualreport to view the entire Annual Report online. 2012 Annual Report (Essentials) 42 YEARS. 42 REASONS. Please visit jdrf.org/2012annualreport to view the entire Annual Report online. Table of Contents CEO Message ...........................................................3 JDRF Supporters ....................................................5 Financials ................................................................24 Leadership ..............................................................25 About JDRF JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Type 1 diabetes is an autoimmune disease that strikes both children and adults. Unrelated to diet or lifestyle, T1D causes lifelong dependence on injected or pumped insulin and carries the constant danger of life-threatening complications. It requires intensive, 24/7 management. There are no days off, and there is no cure. Parents founded JDRF in 1970 to help their children with T1D by funding research to find a cure for this poorly understood and often deadly disease. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF has grown to become the largest nongovernmental funder of T1D research. JDRF has awarded more than $1.7 billion to diabetes research since our founding. Our goal is simple: we want to create a world without T1D. JDRF is the only global organization with a strategic plan to bring a continuous stream of life-changing therapies, and ultimately, a cure for T1D. 2 Please visit jdrf.org/2012annualreport to view the entire Annual Report online. CEO Message A Vision for the Future Our 2012 Annual Report is a JDRF isn’t just imagining keeping patients healthy celebration of JDRF’s 42nd this future. We’re making it and safe until our vision is year highlighting many of happen. JDRF is the only achieved. the amazing supporters and global organization with initiatives that make us the a strategic plan to bring We’re delivering a sustained global leader in T1D funding a continuous flow of life- stream of new, life-changing we are today. The progress changing therapies and, therapies. Underlying we have made in 42 years is ultimately, a cure for T1D. JDRF’s strategy is our work tremendous and our vision Our past investments have to optimize funding across for the future has never been yielded significant advances. the translational research clearer or stronger: a world without T1D. “I believe that one day in the future, In this world: we will declare victory and eliminate • Children with T1D and type 1 diabetes entirely—and JDRF their parents sleep through the night without will have led the way.” fear They have also taught us that continuum—from early • An intelligent pump there will likely be no single stage development through eliminates dangerous “eureka” moment that will delivery to patients. The high and low blood-sugar cause T1D to vanish all at most strategic allocation levels once. Instead, we know that of resources should create • A single daily insulin progress towards a cure will improvements that will injection maintains tight be a series of breakthroughs deliver relatively near-term control with no carb across different therapeutic meaningful clinical impact, counting approaches occurring on as well as ensure there is different timelines. JDRF’s active academic and industry • Developing T1D is no strategic plan for research engagement in early stages longer a concern for you funding will ensure there is an of the pipeline necessary or your loved ones ongoing stream of programs to support subsequent • There is no carb counting, underway to develop and generations of therapeutic no injections, no testing... commercialize therapies that interventions. no T1D lessen the impact of T1D— 3 Please visit jdrf.org/2012annualreport to view the entire Annual Report online. By driving investment across • The body’s ability to what we need is significant. the pipeline, we envision a regenerate islets to We’re doing all we can to cascade of progress that will restore normal glucose bridge that gap, but we need occur over the next 20 years. control while preventing your help. Your continued While we cannot predict the re-attack of the support will help change the exactly what the future holds, immune system; pace of T1D advancements, given the JDRF-funded accelerating progress down • Secondary prevention research underway today this the path to improving lives therapies that slow or progress is likely to include: and curing T1D. halt the progression • Progressive elimination of T1D before insulin Please join us in creating this of blood-glucose testing dependence; and future by giving to JDRF and automation of insulin • Primary prevention today. T1D doesn’t wait—and delivery through a series through universal neither can JDRF. of artificial pancreas childhood immunization. systems currently in Thank you for all that you do clinical trials; We’re uniquely positioned to for JDRF. • Ability to identify create a future without T1D. those most at risk for developing complications Driving this ambitious of T1D; research progress will require substantial annual • An implantable, islet cell investments to reach our Jeffrey Brewer replacement therapy goal of living in a time when that can restore insulin President and Chief Executive T1D is spoken about in the independence and Officer past tense. We know the eliminate the need for path forward is expensive immune suppression; and will take more than the • Glucose responsive $530 million JDRF has at insulin that supports a work around the globe today single shot of insulin per advancing our goals. The gap day or week; between what we have and 4 Please visit jdrf.org/2012annualreport to view the entire Annual Report online. FISCAL YEAR 2012 JDRF Supporters JDRF is the global leader in funding T1D research because of the continued support of our devoted donors. Every dollar we spend on research comes from you. Thank you for helping JDRF to bring life- changing therapies and, one day, a cure for T1D. JDRF Walk to Cure Diabetes ........................................6 Gala .........................................................................................7 Corporate Partners ...........................................................8 Major Donors and Partners ............................................9 BETA Society Members ................................................. 21 Stem Cell Research Fund ............................................ 22 5 Please visit jdrf.org/2012annualreport to view the entire Annual Report online. FISCAL YEAR 2012 JDRF Walk to Cure Diabetes The JDRF Walk to Cure Diabetes Program thanks all of our passionate and dedicated families, volunteers, local businesses, and corporations. Your support of the Walk is essential to JDRF’s fundraising strength and global growth. We also express our deepest gratitude to our many corporate partners for their commitment and support of the JDRF Walk to Cure Diabetes, both nationally and internationally. We extend a special thank-you to our national Walk partners: Advance Auto Parts, Ford Motor Company, Marshalls, Hy-Vee, Inc., Roche, and Walgreens. Congratulations to the FY2012 family Walk teams that raised $75,000 or more! Cohn Sisters: Mackenzie’s MM and Schuyler’s Cute Cupcakes Sydney’s SuperStars New York Chapter Eastern PA/Delaware Chapter Punkin’s Peeps Tessa’s Troopers New York Chapter Los Angeles Chapter Mimi’s Marchers Michael’s Legal Eagles/Kiwanis Long Island Chapter New York Chapter Harmelin Family Team Charlie’s Angels Eastern PA/Delaware Chapter Los Angeles Chapter 6 Please visit jdrf.org/2012annualreport to view the entire Annual Report online. FISCAL YEAR 2012 Gala We are pleased to recognize below the Honorees who helped lead their chapters in raising more than $100,000 through the 2012 Gala Program. Thank you to all the guests, supporters, and volunteers who make each JDRF Gala so successful and inspirational. Patrick and Shauna McFeeley Leanne DeShong Barrick Gold North America and Greater Western Carolinas Chapter Shook, Hardy & Bacon LLP Newmont Mining Corporation Kansas City Chapter Northern Nevada Branch Jerzy Gruhn Novo Nordisk David and Wendy Novak Linda Tharby Eastern PA/Delaware Chapter Yum! Brands, Inc. BD Medical Kentucky Chapter The Byrne Family John J. McDonough Northern NJ–Rockland County Florida Suncoast Chapter Shelby Notkin, Michelle Notkin Chapter Rosen, and Zach Rosen Dr. Bruce Bode Dr. Kevin Kaiserman The Terry Gallagher Family Georgia Chapter Linda Wallem, Stephen Wallem, and Rocky Mountain Chapter Showtime’s Nurse Jackie Genentech, Inc. Los Angeles Chapter Dr. Mitchell Eisenberg Greater Bay Area Chapter Sheridan Healthcare Ron Shapiro South Florida Chapter Anheuser-Busch Companies Shapiro Negotiations Institute Greater Missouri & Southern Illinois Maryland Chapter The Braswell Family Chapter Triangle/Eastern North Carolina Wade and Susan Kotula Chapter Mr. and Mrs. Stephen P. Sparkman II Northern Tool + Equipment Casey Auto Group MinnDakotas Chapter Arlo and Barbara DeKraai Hampton Roads Chapter Hille Foundation Bill Hornbuckle Gary and Anita Rathburn John J. McDonough MGM Resorts International Oklahoma/Northwest Arkansas Illinois Chapter Nevada Chapter Chapter—Tulsa Green Country Branch Michael Alter, Karen Case, Marci Leslie and Michael Weintraub Eisenstein and John Treece, and New England Chapter—Bay State Highmark Inc. Glen Tullman Branch Western Pennsylvania Chapter Illinois Chapter Liam McGee